Mice[1]
Female CD-1 mice (8-10 weeks of age) are dosed i.v. or per oswith SP600125 in PPCES vehicle (30% PEG-400/20% polypropylene glycol/15% Cremophor EL/5% ethanol/30% saline), final volume of 5 mL/kg, 15 min before i.v. injection with LPS in saline (0.5 mg/kg). At 90 min, a terminal bleed is obtained from the abdominal vena cava, and the serum is recovered. Samples are analyzed for mouse TNF-α by using an ELISA.
Rats[4]
A total of 40 male Wistar rats are randomly divided into four groups (n=10): the control group, LPS group, normal saline group (NS) and the SP600125 group. Acute lung injury (ALI) is induced via intratracheal injection of LPS. Normal saline or SP600125 is administered via intraperitoneal injection (15 mg/kg) 10 min after the LPS injection.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
SP600125 是一种口服有效的,可逆的,ATP竞争性的 JNK 抑制剂,抑制 JNK1, JNK2 和 JNK3 的 IC50 分别为 40,40,90 nM。SP600125 是一种有效的铁死亡 (...SP600125 | SP 600125 | SP-600125 | JNK | Autophagy | Apoptosis | Ferroptosis | c-Jun N-terminal kinase | reversible | ATP-competitive | phosphorylation | Inhibitor | inhibitor | inhibitSP600125 是一种口服有效的，可逆的，ATP竞争性的 JNK 抑制剂，抑制 JNK1， JNK2 和 JNK3 的 IC50 分别为 40，40，90 nM。SP600125 是一种有效的铁死亡 (ferroptosis) 抑制剂。SP600125 抑制自噬 (autophagy)，诱导凋亡 (apoptosis)。- 高纯度，全球文献引用。SP600125
本文链接： http://spchemical.immuno-online.com/view-721404.html
